Evidence map›Paper›PMID 28166686›Full record

ArticlePharmaceutical biology2017

Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats.

Batool Rahmati, Zahra Kiasalari, Mehrdad Roghani, Mohsen Khalili, Fariba Ansari

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Phenolic Compounds and Pharmacological Potential ofPlants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Essential Oil ofPlants (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Life (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Antihyperglycemic Effect ofPharmaceutics · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. A New Eucalyptol-Rich Lavender (Molecules (Basel, Switzerland) · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Batool Rahmatia Neurophysiology Research Center, Shahed University , Tehran , Iran.
Zahra Kiasalaria Neurophysiology Research Center, Shahed University , Tehran , Iran.
Mehrdad Roghania Neurophysiology Research Center, Shahed University , Tehran , Iran.
Mohsen Khalilia Neurophysiology Research Center, Shahed University , Tehran , Iran.
Fariba Ansarib Department of Physiology , School of Medicine, Shahed University , Tehran , Iran.
Shahed University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAnxiety and depression are common in Alzheimer's disease (AD). Despite some evidence, it is difficult to confirm Lavandula officinalis Chaix ex Vill (Lamiaceae) as an anxiolytic and antidepressant drug.

objectiveThe effects of L. officinalis extract were studied in scopolamine-induced memory impairment, anxiety and depression-like behaviour. MATERIALS AND

methodsMale NMRI rats were divided into control, scopolamine alone-treated group received scopolamine (0.1 mg/kg) intraperitoneally (i.p.), daily and 30 min prior to performing behavioural testing on test day, for 12 continuous days and extract pretreated groups received aerial parts hydro alcoholic extract (i.p.) (100, 200 and 400 mg/kg), 30 min before each scopolamine injection. Memory impairment was assessed by Y-maze task, while, elevated plus maze and forced swimming test were used to measure anxiolytic and antidepressive-like activity.

resultsSpontaneous alternation percentage in Y maze is reduced by scopolamine (36.42 ± 2.60) (p ≤ 0.001), whereas lavender (200 and 400 mg/kg) enhanced it (83.12 ± 5.20 and 95 ± 11.08, respectively) (p ≤ 0.05). Also, lavender pretreatment in 200 and 400 mg/kg enhanced time spent on the open arms (15.4 ± 3.37 and 32.1 ± 3.46, respectively) (p ≤ 0.001). On the contrary, while immobility time was enhanced by scopolamine (296 ± 4.70), 100, 200 and 400 mg/kg lavender reduced it (193.88 ± 22.42, 73.3 ± 8.25 and 35.2 ± 4.22, respectively) in a dose-dependent manner (p ≤ 0.001). DISCUSSION AND

conclusionLavender extracts improved scopolamine-induced memory impairment and also reduced anxiety and depression-like behaviour in a dose-dependent manner.

Indexed as

ScopolamineAnimalsAnti-Anxiety AgentsAntidepressive AgentsAnxietyBehavior, AnimalChromatography, High Pressure LiquidDepressionDisease Models, AnimalDose-Response Relationship, DrugEthanolLavandulaMaleMaze LearningMemoryMemory DisordersAnti-Anxiety AgentsAntidepressive AgentsEthanolPhenolsPlant ExtractsScopolamineSolventsanxietydepressionelevated plus mazeforced swimmingMemory impairmentY maze

Identifiers

PMID28166686
PMCPMC6130744
OpenAlexW2586696336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.